demonstrated that MUC1, a tumor-associated antigen in breast cancer, triggers a robust immune response, marked by the production of anti-glycoprotein serum IgG, IgA, and IFNɣ, effectively mobilizing the immune system against breast cancer proliferation and invasion (165). This evidence concerns the gene MUC1 and neoplasm.